This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
More Children's Medications From Shuttered McNeil Plant Recalled
Blacksmith Brands Pulling Four PediaCare Products From Market as Precaution
By News Staff
McNeil closed that facility after the FDA issued a highly critical report (17-page PDF; About PDFs) on April 30 that said the plant did not meet the agency's good manufacturing practices requirements.
That same day, McNeil announced it was recalling all unexpired lots of certain brand-name OTC children's and infants' liquid medications -- including more than 40 variations of Tylenol, Motrin, Zyrtec and Benadryl products -- because of manufacturing deficiencies at the Fort Washington facility.
Blacksmith said in its release that it had not received any consumer complaints or reports of adverse events associated with the PediaCare products. However, the company said that although the potential for serious adverse events is remote, consumers who have purchased the recalled PediaCare products are advised to discontinue their use.
The four PediaCare items involved in the recall are
- PediaCare Multi-Symptom Cold,
- PediaCare Long-Acting Cough,
- PediaCare Decongestant and
- PediaCare Allergy & Cold.
Blacksmith said it plans to shift production of the recalled products to other manufacturing plants and expects to resume shipping in July.
Consumers with questions about the recalled products may contact Blacksmith at (888) 474-3099. Adverse events associated with the use of these products should be reported to the FDA's MedWatch Program.
FDA Conducting Company-wide Investigation of McNeil Consumer Healthcare
Third Recall of Children's, Infants' Products in Less Than One Year Sparks Action
(5/18/2010)
McNeil Recalls Children's, Infants' Tylenol, Motrin, Benadryl, Zyrtec
Generic Versions of Products Not Affected, Says FDA
(5/4/2010)
McNeil Recalling Hundreds of Lots of Contaminated OTC Medications
FDA Criticizes Manufacturer for Handling of Investigation
(1/18/2010)
Additional Resources
Blacksmith Brands News Release: "Blacksmith Brands Announces Nationwide Voluntary Recall Of Four PediaCare Children's Products"
(May 28, 2010)
McNeil Product Recall Information
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
